EBITDA Margin ratio Analysis of AcelRx Pharmaceuticals Inc - Deep Dive
Latest FY EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-950.58
Period Ending - Dec-22
Excellent EBITDA Margin
2855.34
Growth
-133.29 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-2330.41
Most recent Quarter EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-1607.47
EBITDA Margin Analysis of AcelRx Pharmaceuticals Inc
Ebitda Margin Ratio of AcelRx Pharmaceuticals Inc with value of -2330.41 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
Ebitda Margin Ratio of AcelRx Pharmaceuticals Inc with value of -1607.47 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Dec-23. |
EBITDA Margin Ratio of ACRX drastically fell by -133.29 % this year. |
EBITDA Margin Ratio with value of 2855.34 was highest in Year Dec-22 in last Five Years. |
EBITDA Margin Ratio with value of -2200.57 was lowest in Year Dec-19 in last Five Years. |
Latest EBITDA Margin Ratio with value of -950.58 is lower than Average EBITDA Margin of -408.02 in last five years. |
Ebitda Margin of AcelRx Pharmaceuticals Inc is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months |
Other EBITDA Margin Related Info of ACRX that may interest you.
AcelRx Pharmaceuticals Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
ACRX | 0.8945 | 0.86 | 4.01 % | Drug Manufacturers-Specialty & Generic |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..EBITDA Margin Related Ratios
NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical EBITDA Margin of AcelRx Pharmaceuticals Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
EBITDA Margin | -950.58 | 2855.34 | -1094.04 | -650.24 | -2200.57 | -1581.31 | -455.63 |
Change | -133.29 % | 360.99 % | -68.25 % | 70.45 % | -39.16 % | -247.06 % | -172.83 % |
FY Chart of EBITDA Margin of AcelRx Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)